Chemical Compound

2-(3-((2S,5R,8S,11S,14R,17S,20S,23R,26S,29S,32R,35S,38Z)-32-benzyl-17-butan-2-yl-38-ethylidene-14-((1R)-1-hydroxyethyl)-20-((1S)-1-hydroxyethyl)-5-((4-hydroxyphenyl)methyl)-8-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-penta(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecazacyclononatriacont-2-yl)propyl)guanidine

CAS Registry Number 329359-86-6
2-(3-((2S,5R,8S,11S,14R,17S,20S,23R,26S,29S,32R,35S,38Z)-32-benzyl-17-butan-2-yl-38-ethylidene-14-((1R)-1-hydroxyethyl)-20-((1S)-1-hydroxyethyl)-5-((4-hydroxyphenyl)methyl)-8-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-penta(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecazacyclononatriacont-2-yl)propyl)guanidine 结构式
Primary record

2-(3-((2S,5R,8S,11S,14R,17S,20S,23R,26S,29S,32R,35S,38Z)-32-benzyl-17-butan-2-yl-38-ethylidene-14-((1R)-1-hydroxyethyl)-20-((1S)-1-hydroxyethyl)-5-((4-hydroxyphenyl)methyl)-8-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-penta(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecazacyclononatriacont-2-yl)propyl)guanidine

库存
9,714 克
纯度
98.3 %
CAS
329359-86-6

化合物标识与属性

CAS
329359-86-6
PubChem CID
70697801
SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/C)/C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)[C@@H](C)O)C(C)C)CCSC)CC2=CC=C(C=C2)O)CCCN=C(N)N)C(C)C)CC3=CC=CC=C3)C(C)C)C(C)C)C(C)C)[C@@H](C)O
Canonical SMILES
C/C=C1/NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCN=C(N)N)NC1=O

名称与同义词

  • Tolybyssidin B
  • TolybyssidinB
  • RefChem:933178
  • CHEBI:66250
  • DTXSID301319225
  • DTXCID901748648
  • J1.495.028A
  • Q27134793
  • Cyclo[Phe-Val-2-ethylidene-Gly-Arg-Tyr-Met-Val-Thr-Ile-Thr-Val-Val-Val-]
  • 1-{3-[(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38E)-32-benzyl-17-[(2S)-butan-2-yl]-38-ethylidene-5-(4-hydroxybenzyl)-14,20-bis[(1R)-1-hydroxyethyl]-8-[2-(methylsulfanyl)ethyl]-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-penta(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclononatriacontan-2-yl]propyl}guanidine
  • 2-(3-((2S,5R,8S,11S,14R,17S,20S,23R,26S,29S,32R,35S,38Z)-32-benzyl-17-butan-2-yl-38-ethylidene-14-((1R)-1-hydroxyethyl)-20-((1S)-1-hydroxyethyl)-5-((4-hydroxyphenyl)methyl)-8-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-penta(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecazacyclononatriacont-2-yl)propyl)guanidine
  • 2-(3-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38E)-32-benzyl-17-((2S)-butan-2-yl)-38-ethylidene-14,20-bis((1R)-1-hydroxyethyl)-5-((4-hydroxyphenyl)methyl)-8-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-penta(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecazacyclononatriacont-2-yl)propyl)guanidine
  • 329359-86-6
  • N''-{3-[(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38E)-32-Benzyl-17-[(2S)-butan-2-yl]-38-ethylidene-14,20-bis[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-[2-(methylsulfanyl)ethyl]-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-penta(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclononatriacontan-2-yl]propyl}guanidine
  • N-{3-[(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S)-32-benzyl-17-[(2S)-butan-2-yl]-38-ethylidene-14,20-bis[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-[2-(methylsulfanyl)ethyl]-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-11,23,26,29,35-pentakis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclononatriacontan-2-yl]propyl}guanidine